Cost and utility of routine admission laboratory testing for psychiatric inpatients

General Hospital Psychiatry
Y I Sheline, C Kehr

Abstract

We retrospectively evaluated the cost and utility of routine laboratory testing for psychiatric patients admitted to an acute inpatient hospital. Medical records were reviewed for 252 patients accounting for 305 sequential admissions over a recent 3-month period. Of the patient population, 49.6% had one or more coexisting medical illnesses. Overall, 6% of the abnormal laboratory findings resulted in changes in medical management: 49.2% of complete blood counts were abnormal, and 11.6% led to changes in medical management. Of the 20-factor blood chemistry analyses, 86.2% were abnormal, and 4.7% led to changes in medical management. Of the urinalyses, 85.3% were abnormal, and 2.2% led to changes in medical management. Of 277 screening syphilis titers, 5 were positive but only 1 was a potential new finding. The average cost to the facility for laboratory testing was $65 per patient admission, and the average cost per change in medical management resulting from the laboratory studies was $1070.

References

Jul 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·C J Thomas
Jul 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·A W Burke
Aug 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·L ShatinW Brown
Sep 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·D G McLartyA Goldberg
Feb 14, 1976·British Medical Journal·H F Barnard
Aug 1, 1975·Annals of Internal Medicine·C C KorvinJ Stanley
Aug 1, 1989·Archives of General Psychiatry·L M KoranL C Levin
Jun 1, 1988·Archives of Internal Medicine·V A Lawrence, K Kroenke
Jun 1, 1988·Medical Care·F A HubbellL Rucker
Mar 1, 1985·American Journal of Public Health·K DomotoA L Komaroff
Sep 1, 1985·Psychosomatics·T P BeresfordF Blow
Apr 1, 1972·The British Journal of Venereal Diseases·W P DuncanC E Parham
Oct 2, 1972·JAMA : the Journal of the American Medical Association·B Bates, J A Yellin
Apr 1, 1970·American Journal of Clinical Pathology·R E BelliveauD A Nickerson
Jan 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·G D Banks
Sep 1, 1983·General Hospital Psychiatry·R F BarnesF T Ray
Jan 1, 1982·Annual Review of Medicine·E K Koranyi
Nov 1, 1982·Public Health·M B AbdurrahmanP C Suvarnabai
May 1, 1981·The American Journal of Psychiatry·R C HallS K Stickney
Dec 1, 1959·American Journal of Clinical Pathology·R E BELL
Jan 1, 1965·The British Journal of Psychiatry : the Journal of Mental Science·D W DAVIES
Sep 10, 1949·British Medical Journal·R ASHER

❮ Previous
Next ❯

Citations

Oct 7, 2000·General Hospital Psychiatry·B Hutto, A A Adimora
May 16, 1998·General Hospital Psychiatry·E J Mookhoek, I M Sterrenburg-vdNieuwegiessen
Jan 30, 2002·Psychosomatics·B Hutto
Oct 24, 2015·Emergency Medicine Clinics of North America·Veronica TucciNidal Moukaddam
Oct 12, 2004·General Hospital Psychiatry·Robert J GregoryElliot Rodriguez
Sep 30, 2014·Journal of Psychiatric Research·Lisa J ReidyCharles B Nemeroff
Jan 1, 2012·International Journal of Psychiatry in Medicine·J Lopez-CastromanE Baca-Garcia
Dec 22, 2017·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Alyssa ConigliaroRichard Sinert
Aug 31, 2001·The Journal of ECT·J E LaffertyK Isenberg
Jan 3, 2006·Annals of Emergency Medicine·Thomas W LukensUNKNOWN American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Critical Issues in the Diagno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.